A Rare Case of Breast Implant-Associated Diffuse Large B-Cell Lymphoma

Table 1

A listing of DLBCL diagnostic markers [4, 6].

Biomarker expression/genetic alterations	Percentage of cases
CD19, CD20, CD22, CD79A, CD45	Pan B-cell antigens, highly expressed
CD30	25% (anaplastic variant)
BCL2	25-80%
BCL6	70%
CD10	30-60%
MUM1/IRF4	35-65%
CD5	Uncommon, aggressive disease
(14;18) translocation	30%
MYC gene rearranged	5-15%